Memahami Penyakit Paru Interstisial: Pengenalan Dini pada Layanan Kesehatan Primer
DOI:
https://doi.org/10.55175/cdk.v51i4.1092Keywords:
Lung disorder, interstitial lung disease, primary healthcare professionalAbstract
Interstitial lung disease (ILD) encompasses a group of heterogeneous lung disorders with varying etiologies and clinical presentations. Early diagnosis is essential for timely intervention and improved patient outcomes. This mini-review highlights the significance of early diagnosis of ILD in primary health centers, focusing on the benefits and challenges associated with early detection, and the role of primary healthcare professionals in achieving a timely diagnosis. Primary healthcare professionals play a pivotal role in recognizing early signs and symptoms of ILD, conducting preliminary evaluations, and guiding patients through the diagnostic process. Collaborative efforts between primary healthcare professionals, pulmonologists, and radiologists are crucial to overcome these challenges and ensure timely diagnosis.
Downloads
References
Aronson KI, Swigris JJ, Bajwah S, Bianchi P, Corte TJ, Danoff SK, et al. Patient-centered outcomes research in interstitial lung disease: An official american thoracic society research statement. Am J Respir Crit Care Med. 2021;204(2):e3-23.
Kaul B, Cottin V, Collard HR, Valenzuela C. Variability in global prevalence of interstitial lung disease. Front Med. 2021;8:751181.
Wallis A, Spinks K. The diagnosis and management of interstitial lung diseases. BMJ. 2015;350(May):1–12.
Global Burden of Disease Collaborative Network. Global burden of disease study 2019 (GBD 2019) reference life table. Institute for Health Metrics and Evaluation [Internet]. 2019 [cited 2023 September 22]. Available from: https://ghdx.healthdata.org/record/ihme-data/global-burden-disease-study-2019-gbd-2019-reference-life-table.
Shah Gupta R, Koteci A, Morgan A, George PM, Quint JK. Incidence and prevalence of interstitial lung diseases worldwide: A systematic literature review. BMJ Open Respir Res. 2023;10(1):e001291.
Kalchiem-Dekel O, Galvin JR, Burke AP, Atamas SP, Todd NW. Interstitial lung disease and pulmonary fibrosis: A practical approach for general medicine physicians with focus on the medical history. J Clin Med. 2018;7(12):476.
Glasser SW, Hardie WD, Hagood JS. Pathogenesis of interstitial lung disease in children and adults. Pediatr Allergy, Immunol Pulmonol. 2010;23(1):9-14.
Alsomali H, Palmer E, Aujayeb A, Funston W. Early diagnosis and treatment of idiopathic pulmonary fibrosis: A narrative review. Pulm Ther. 2023;9(2):177–93.
Berger K, Kaner RJ. Diagnosis and pharmacologic management of fibrotic interstitial lung disease. Life 2023;13(3):599.
Mikolasch TA, Garthwaite HS, Porter JC. Update in diagnosis and management of interstitial lung Disease. Clin Med J R Coll Physicians London. 2017;17(2):146–53.
Griese M. Etiologic classification of diffuse parenchymal (interstitial) lung diseases. J Clin Med. 2022;11(6):1747.
Adegunsoye A, Ryerson CJ. Diagnostic classification of interstitial lung disease in clinical practice. Clin Chest Med. 2021;42(2):251-61. DOI: 10.1016/j.ccm.2021.03.002.
Sinha A, Patel AS, Siegert RJ, Bajwah S, Maher TM, Renzoni EA, et al. The king’s brief interstitial lung disease (KBILD) questionnaire: An updated minimal clinically important difference. BMJ Open Respir Res. 2019;6(1):e000363.
Rousan LA, Elobeid E, Karrar M, Khader Y. Chest x-ray findings and temporal lung changes in patients with COVID-19 pneumonia. BMC Pulm Med. 2020;20(1):245. DOI: 10.1186/s12890-020-01286-5.
Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner society: Glossary of terms for thoracic imaging. Radiology 2008;246(3):697–722.
Vizioli L, Ciccarese F, Forti P, Chiesa AM, Giovagnoli M, Mughetti M, et al. Integrated use of lung ultrasound and chest X-ray in the detection of interstitial lung disease. Respiration 2017;93(1):15-22. DOI: 10.1159/000452225.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidencebased guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6): 788–824. DOI: 10.1164/rccm.2009-040GL
Maher TM, Wuyts W. Management of fibrosing interstitial lung diseases. Adv Ther. 2019;36(7):1518-31. DOI: 10.1007/s12325-019-00992-9.
Lindell KO. Nonpharmacological therapies for interstitial lung disease. Curr Pulmonol Reports. 2018;7(4):126–32. DOI: 10.1007/s13665-018-0211-6.
Leuschner G, Behr J. Acute exacerbation in interstitial lung disease. Front Med. 2017;4:176.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Altama Latona Sidarta, Menaldi Rasmin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
